安普克
癌症研究
蛋白激酶A
癌细胞
细胞凋亡
信号转导
化学
药理学
癌症
激酶
医学
内科学
生物化学
作者
Jin‐Taek Hwang,Joohun Ha,In Ja Park,Seong-Kyu Lee,Haing Woon Baik,Young Min Kim,Ock Jin Park
出处
期刊:Cancer Letters
[Elsevier]
日期:2007-03-01
卷期号:247 (1): 115-121
被引量:252
标识
DOI:10.1016/j.canlet.2006.03.030
摘要
EGCG [(-)epigallocatechin-3-gallate], a green tea-derived polyphenol, has been shown to suppress cancer cell proliferation, and interfere with the several signaling pathways and induce apoptosis. Practically, there is emerging evidence that EGCG has a potential to increase the efficacy of chemotherapy in patients. We hypothesized that EGCG may exert cell cytotoxicity through modulating AMPK (AMP-activated protein kinase) followed by the decrease in COX-2 expression. EGCG treatment to colon cancer cells resulted in a strong activation of AMPK and an inhibition of COX-2 expression. The decreased COX-2 expression as well as prostaglandin E(2) secretion by EGCG was completely abolished by inhibiting AMPK by an AMPK inhibitor, Compound C. Also, the activation of AMPK was accompanied with the reduction of VEGF (vascular endothelial growth factor) and glucose transporter, Glut-1 in EGCG-treated cancer cells. These findings support the regulatory role of AMPK in COX-2 expression in EGCG-treated cancer cells. Furthermore, we have found that reactive oxygen species (ROS) is an upstream signal of AMPK, and the combined treatment of EGCG and chemotherapeutic agents, 5-FU or Etoposide, exert a novel therapeutic effect on chemo-resistant colon cancer cells. AMPK, a molecule of newly defined cancer target, was shown to control COX-2 in EGCG-treated colon cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI